Monday , October 23 2017

From the Editor

October, 2017

  • 21 October

    Oct 21, 2017


    This week insulin takes a front row in treating diabetes with the information on a new super rapid insulin. This insulin, discussed in this week’s item 2,  gives flexibility at meal time that has been lacking for a lot of patients. Also, as Animas leaves the insulin pump market, a ...

    Read More »

Latest Articles

October, 2017

Test Your Knowledge

Lifestyle Modifications

Your 42-year-old, overweight patient was diagnosed with type 2 diabetes (A1C 7.7%) five months ago. You discussed the diagnosis with him, prescribed metformin, and provided lifestyle modification education resources. He missed his follow-up appointment, so you called him to schedule a return visit. At this appointment, he shares some of the positive lifestyle modifications he has made and that he has been taking his metformin consistently. He currently takes 2,000 mg metformin per day. At this visit, his A1C is 9.4%. All of the following are reasonable treatment options EXCEPT:


Correct Answer: A. Metformin + Lifestyle modifications

Educational Critique: According to ADA/EASD guidelines, once A1C=9%, glycemic targets are hard to achieve with monotherapy. If, after approximately a 3-month treatment period, monotherapy does not achieve or maintain target A1C, a second oral agent, a GLP-1 receptor agonist or a basal insulin should be added. Adding a second agent is associated with an additional A1C reduction of 1%. A, B, and C are all acceptable 2-drug combinations. Additional education, support and more frequent follow-up would be warranted.  Diabetes Care Jan. 2017


More Articles

October, 2017